(Press-News.org) Traumatized people who take a class of common blood pressure medications tend to have less severe post-traumatic stress symptoms, researchers have found.
The finding suggests that ACE (angiotensin converting enzyme) inhibitors or ARBs (angiotensin receptor blockers) could be valuable tools for treating or preventing post-traumatic stress disorder.
The results were published online May 1 in the Journal of Clinical Psychiatry.
"These results are particularly exciting because it's the first time ACE inhibitors and ARBs have been connected to PTSD, and it gives us a new direction to build on," says senior author Kerry Ressler, MD, PhD, associate professor of psychiatry and behavioral sciences at Emory University School of Medicine and a researcher at Yerkes National Primate Research Center.
"These data come from an observational study, not a randomized clinical trial, so it is important to limit our interpretation until larger, placebo-control, double-blinded trials can be performed. Still, they provide evidence from a human population that could be followed up in a rigorous controlled trial. This class of medications has been widely prescribed for hypertension for years and their safety profiles are well known, so our results could be translated into action relatively quickly."
The findings emerge from the Grady Trauma Project, an observational study of more than 5,000 low-income Atlanta residents with high levels of exposure to violence and physical and sexual abuse, resulting in high rates of civilian PTSD.
All 505 participants in this study were exposed to at least one traumatic event, and around 35 percent of them (180) met the criteria for diagnosis with PTSD. Out of 98 participants taking ACE inhibitors or ARBs, generally for the primary purpose of blood pressure control, 26 had a PTSD diagnosis.
People with PTSD can experience three types of symptoms: hyperarousal, avoidance/numbing, and intrusive thoughts. All the participants in the study reported how often they experienced these symptoms and the responses were compiled into a PTSD symptom score.
Patients taking ACE inhibitors or ARBs had an approximately 30 percent decrease in PTSD symptom scores, but no significant differences were apparent for those taking other blood pressure medications, including beta-blockers, calcium channel blockers, and diuretics. In particular, individuals taking ACE inhibitors or ARBs tended to have lower levels of hyperarousal and intrusive thoughts.
The results underline the physiological basis for the body's stress responses in PTSD, and links to blood pressure regulation. Both ACE inhibitors and ARBs interfere with angiotensin II, a hormone that regulates blood pressure. Ressler says his laboratory has begun investigating the role of angiotensin II in mice, in regions of the brain known to be important for stress and fear responses, such as the amygdala and bed nucleus of the stria terminalis. These data suggest that this class of medication may both decrease the body's physiological response to stress in the cardiovascular system as well as decrease the brain's response to stress.
The negative finding with beta blockers was somewhat surprising, Ressler says. Some musicians and athletes take beta blockers to relieve performance anxiety symptoms, and some early clinical studies have examined whether they can be used to treat PTSD. Beta blockers diminish the body's response to the stress hormones norepinephrine and epinephrine.
"Beta blockers did appear to have a trend toward an effect, but the effects of the angiotensin medications were stronger, and when people in our study took both, only the angiotensin medications survived statistical analysis" Ressler says. "Beta blockers may be useful in the moment for decreasing social or performance anxiety, but their efficacy in PTSD treatment is still an open question."
###
The first author is a graduating medical student at Emory, Nayla Khoury. Ressler, a Howard Hughes Medical Institute Investigator, is co-director of the Grady Trauma Project, along with co-author Bekh Bradley, PhD, assistant professor of psychiatry and behavioral sciences at Emory and director of the Trauma Recovery Program at the Atlanta Veterans Affairs Medical Center.
The research was supported by the National Institutes of Health, the American Foundation for Suicide Prevention and the Burroughs Wellcome Fund.
Reference:
The renin-angiotensin pathway in posttraumatic stress disorder: ACE inhibitor and ARB medications are associated with fewer traumatic stress symptoms. N.M. Khoury, P. J. Marvar, C.F. Gillespie, A. Wingo, A. Schwartz, B. Bradley, M. Kramer, and K.J. Ressler. J. Clin. Psych. (2012)
Blood pressure drugs linked with lower PTSD symptoms
2012-05-02
ELSE PRESS RELEASES FROM THIS DATE:
Treating childhood obesity: A family affair
2012-05-02
WINSTON-SALEM, N.C. – May 1, 2012 – With nearly one-third of American children being overweight or obese, doctors agree that there is an acute need for more effective treatments. In many weight management programs, the dropout rate can be as high as 73 percent, and even in successful programs, the benefits are usually short term.
Although family-based approaches to pediatric obesity are considered the gold standard of treatment, theories of the family and how it functions have not been incorporated into effective interventions, according to a study published in the May ...
National poll: Low cost, lifesaving services missing from most older patients' health care
2012-05-02
New York, NY(May 1, 2012) – Large majorities of older Americans experience significant and troubling gaps in their primary care, according to a new national survey, "How Does It Feel? The Older Adult Health Care Experience," released today by the John A. Hartford Foundation, a champion for improved geriatric care and longtime partner of the Hartford Institute for Geriatric Nursing at New York University's College of Nursing.
The poll focuses exclusively on Americans age 65 and older and assesses whether, in the past 12 months, patients received seven important medical ...
Aaron Wargo Joins Corcentric as National Account Manager
2012-05-02
Corcentric, a leading provider of Accounts Payable automation solutions, today announced the appointment of Aaron Wargo to the role of National Account Manager. Aaron brings more than 18 years of experience in Demand and Account Management and Sales in the Finance and SaaS Software industries.
Previously, Aaron served as Manager of Demand Management at Ariba Financial Solutions, where he was responsible for managing a multi-lingual team tasked with creating qualified sales throughout North America, South America, and Europe. Before joining Ariba Financial Solutions, ...
Jurassic pain: Giant 'flea-like' insects plagued dinosaurs 165 million years ago
2012-05-02
CORVALLIS, Ore. – It takes a gutsy insect to sneak up on a huge dinosaur while it sleeps, crawl onto its soft underbelly and give it a bite that might have felt like a needle going in – but giant "flea-like" animals, possibly the oldest of their type ever discovered, probably did just that.
And a few actually lived through the experience, based on the discovery by Chinese scientists of remarkable fossils of these creatures, just announced in Current Biology, a professional journal.
These flea-like animals, similar but not identical to modern fleas, were probably 10 ...
Small Businesses Encouraged to Secure Their Premises
2012-05-02
Whatishealthandsafety.co.uk has urged small businesses to increase the health and safety of their workplace. The reputable online resource has warned company owners about the dangers of theft and is keen to minimise criminal activity.
According to the website, a whole range of organisations are targeted by thieves every year. Many companies struggle to cope with a lack of supplies and are unable to continue working throughout these turbulent economic times. As a result, health and safety experts have encouraged entrepreneurs to stock up on branded asset tags and are ...
McLean Report on nanotechnology that may enhance medication delivery and improve MRI performance
2012-05-02
Belmont, MA - Researchers at Harvard-affiliated McLean Hospital have shown a new category of "green" nanoparticles comprised of a non-toxic, protein-based nanotechnology that can non-invasively cross the blood brain barrier and is capable of transporting various types of drugs.
In an article published May 1, 2012 online in PLoS ONE, Gordana Vitaliano, MD, director of the Brain Imaging NaNoTechnology Group at the McLean Hospital Imaging Center, reported that clathrin protein, a ubiquitous protein found in human, animal, plant, bacteria and fungi cells, can been modified ...
Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival
2012-05-02
To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.
Sarcomas are relatively rare forms of cancer. In contrast to carcinomas, which arise from epithelial cells (in breast, colon and lung cancers, for example), sarcomas are tumors ...
Sirma Mobile Inc. Announces Release of New App That Allows Businesses to Effectively Manage Staff Attendance
2012-05-02
Sirma Mobile, Inc. today announced the release of mTimeCard, a free mobile app for both iPhone and Android that lets SMBs easily monitor their employees' timekeeping and attendance.
"It is not only staff administration, but managing most of a company's marketing activities, checking inventory or dealing with suppliers, for example. A simple time-and-effort-saving solution will be highly appreciated," said business owners interviewed during the pilot tests.
To make it easier for vendors to monitor attendance, Sirma Mobile has developed a mobile application ...
Anti-HIV drug use during pregnancy does not affect infant size, birth weight
2012-05-02
Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study. However, at 1 year of age, children born to the tenofovir-treated mothers were slightly shorter and had slightly smaller head circumference—about 1 centimeter each, on average—than were infants whose mothers did not take tenofovir. ...
Researchers gain better understanding of mechanism behind tau spreading in the brain
2012-05-02
Researchers at Mount Sinai School of Medicine have gained insight into the mechanism by which a pathological brain protein called tau contributes to the progression of Alzheimer's disease (AD) and other neurodegenerative disorders. This finding, published in the most recent issue of the Journal of Biological Chemistry, may provide the basis for future investigations on how to prevent tau from damaging brain circuits involved in cognitive function.
Previous studies have shown that the abnormal folding, or misfolding, and buildup of tau are key neuropathological features ...